Generation of prion transmission barriers by mutational control of amyloid conformations

Nature

Volumn 424, Issue 6951, 2003, Pages 948-951

  Chien, Peter ^a   DePace, Angela H ^a   Collins, Sean R ^a   Weissman, Jonathan S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONFORMATIONS; DISEASES; POLYPEPTIDES; PROTEINS; TOXICITY;

MUTATIONS;

MUTAGENESIS;

AMYLOID BETA PROTEIN; PRION PROTEIN;

MEDICINE; PRION DISEASE;

ARTICLE; DISEASE TRANSMISSION; FUNGUS TRANSMISSION; GENE MUTATION; NEUROLOGIC DISEASE; NEUROTOXICITY; NONHUMAN; PHENOTYPE; PLASMID; PRION DISEASE; PRIORITY JOURNAL; PROTEIN FOLDING; YEAST;

FUNGAL PROTEINS; POINT MUTATION; PRIONS; PROTEIN CONFORMATION; PROTEIN DENATURATION; RECOMBINANT FUSION PROTEINS; SACCHAROMYCES CEREVISIAE PROTEINS; SENILE PLAQUES;

FUNGI;

EID: 0042358923     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/nature01894     Document Type: Article

References (29)

1. Dobson, C. M. The structural basis of protein folding and its links with human disease. Phil. Trans. R. Soc. Lond. B 356, 133-145 (2001).
2. DePace, A. H. & Weissman, J. S. Origins and kinetic consequences of diversity in Sup35 yeast prion fibers. Nature Struct. Biol. 9, 389-396 (2002).
3. Baxa, U., Speransky, V., Steven, A. C. & Wickner, R. B. Mechanism of inactivation on prion conversion of the Saccharomyces cerevisiae Ure2 protein. Proc. Natl Acad. Sci. USA 99, 5253-5260 (2002).
4. +], a heritable prion-like factor of S. cerevisiae. Cell 89, 811-819 (1997).
5. 2-Microglobulin and its deamidated variant, N17D form amyloid fibrils with a range of morphologies in vitro. J. Mol. Biol. 313, 559-571 (2001).
6. Lashuel, H. A., Hartley, D., Petre, B. M., Walz, T. & Lansbury, P. T. Jr Neurodegenerative disease: amyloid pores from pathogenic mutations. Nature 418, 291 (2002).
7. Collinge, J. Prion diseases of humans and animals: their causes and molecular basis. Annu. Rev. Neurosci. 24, 519-550 (2001).
8. Santoso, A., Chien, P., Osherovich, L. Z. & Weissman, J. S. Molecular basis of a yeast prion species barrier. Cell 100, 277-288 (2000).
9. Come, J. H., Fraser, P. E. & Lansbury, P. T. Jr A kinetic model for amyloid formation in the prion diseases: importance of seeding. Proc. Natl Acad. Sci. USA 90, 5959-5963 (1993).
10. Chernoff, Y. O. et al. Evolutionary conservation of prion-forming abilities of the yeast Sup35 protein. Mol. Microbiol. 35, 865-876 (2000).
11. Kushnirov, V. V., Kochneva-Pervukhova, N. V., Chechenova, M. B., Frolova, N. S. & Ter-Avanesyan, M. D. Prion properties of the Sup35 protein of yeast Pichia methanolica. EMBO J. 19, 324-331 (2000).
12. +] "prions" that are crosstransmissible and susceptible beyond a species barrier through a quasi-prion state. Mo. Cell 7, 1121-1130 (2001).
13. Uptain, S. M. & Lindquist, S. Prions as protein-based genetic elements. Annu. Rev. Microbiol. 56, 703-741 (2002).
14. King, C. Y. et al. Prion-inducing domain 2-114 of yeast Sup35 protein transforms in vitro into amyloid-like filaments. Proc. Natl Acad. Sci. USA 94, 6618-6622 (1997).
15. Derkatch, I. L., Chernoff, Y. O., Kushnirov, V. V., Inge-Vechtomov, S. G. & Liebman, S. W. Genesis and variability of [PSI] prion factors in Saccharomyces cerevisiae. Genetics 144, 1375-1386 (1996).
16. +] and their prion-specific effects. Curr. Biol. 10, 1443-1446 (2000).
17. +], a prion-like form of release factor eRF3. EMBO J. 18, 1182-1191 (1999).
18. +] prion generation in yeast: characterization of the 'strain' difference. Yeast 18, 489-497 (2001).
19. +] are distinguished by their efficiencies of prion-mediated conformational conversion. EMBO J. 20, 6236-6245 (2001).
20. King, C. Y. Supporting the structural basis of prion strains: induction and identification of [PSI] variants. J. Mol. Biol. 307, 1247-1260 (2001).
21. Chien, P. & Weissman, J. S. Conformational diversity in a yeast prion dictates its seeding specificity. Nature 410, 223-227 (2001).
22. DePace, A. H., Santoso, A., Hillner, P. & Weissman, J. S. A critical role for amino-terminal glutamine/asparagine repeats in the formation and propagation of a yeast prion. Cell 93, 1241-1252 (1998).
23. Barron, R. M. et al. Changing a single amino acid in the N-terminus of murine PrP alters TSE incubation time across three species barriers. EMBO J. 20, 5070-5078 (2001).
24. Mastrianni, J. A. et al. Inherited prion disease caused by the V2101 mutation: transmission to transgenic mice. Neurology 57, 2198-2205 (2001).
25. Peretz, D. et al. A change in the conformation of prions accompanies the emergence of a new prion strain. Neuron 34, 921-932 (2002).
26. Bartz, J. C., Bessen, R. A., McKenzie, D., Marsh, R. F. & Aiken, J. M. Adaptation and selection of prion protein strain conformations following interspecies transmission of transmissible mink encephalopathy. J. Virol. 74, 5542-5547 (2000).
27. Hill, A. F., Antoniou, M. & Collinge, J. Protease-resistant prion protein produced in vitro lacks detectable infectivity. J. Gen. Virol. 80, 11-14 (1999).
28. Baskakov, I. V., Legname, G., Baldwin, M. A., Prusiner, S. B. & Cohen, F. E. Pathway complexity of prion protein assembly into amyloid. J. Biol. Chem., 277, 21140-21148 (2002).
29. Post, K., Brown, D. R., Groschup, M., Kretzschmar, H. A. & Riesner, D. Neurotoxicity but not infectivity of prion proteins can be induced reversibly in vitro. Arch. Virol. Suppl. 16, 265-273 (2000).